ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

35,443Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 2680

$180K Total Retail Price of All Prescriptions

Rank: 1588 out of 2680

480 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 32,763 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$5 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

74 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 1,282 1,228 1 4
NAMENDA 1,181 1,165 2 43
LISINOPRIL 1,156 1,039 3 5
FUROSEMIDE 1,096 1,053 4 7
OMEPRAZOLE 1,085 980 5 2
CALCIUM 600 + VIT D 961 853 10 6 204
DONEPEZIL HCL 955 953 7 28
ATORVASTATIN CALCIUM 919 789 8 10
PAIN RELIEVER 904 871 10 9 213
ASPIRIN 736 670 10 10 240
ASPIRIN EC 679 661 11 199
AMLODIPINE BESYLATE 676 627 12 3
TRAMADOL HCL 629 620 13 33
SENNA 624 540 10 14 242
CYMBALTA 555 421 15 56
METOPROLOL SUCCINATE 534 514 16 11
SERTRALINE HCL 467 446 17 23
VITAMIN B-12 455 448 10 18 271
METOPROLOL TARTRATE 426 417 19 8
WARFARIN SODIUM 412 405 20 12
POTASSIUM CHLORIDE 389 387 21 29
VITAMIN D2 352 324 22 176
LORATADINE 345 339 23 259
PREDNISONE 319 317 24 45
CITALOPRAM HBR 304 300 25 22
FLUOXETINE HCL 301 279 26 76
PANTOPRAZOLE SODIUM 300 296 27 44
CARVEDILOL 292 251 28 27
CLOPIDOGREL 289 283 29 30
TAMSULOSIN HCL 286 278 30 25
RISPERIDONE 276 276 31 67
ALBUTEROL SULFATE 256 227 32 97
HYDROCODONE-ACETAMINOPHEN 254 226 S3 33 13
MIRTAZAPINE 250 238 34 48
CALMOSEPTINE 234 200 10 35 285
FERROUS SULFATE 228 216 10 36 289
CARBIDOPA-LEVODOPA 222 197 37 88
RANITIDINE HCL 213 167 38 35
DIGOXIN 212 212 39 59
D3-50 211 195 10 40 338
GABAPENTIN 206 138 41 21
NYSTOP 202 185 42 183
ALLOPURINOL 200 148 43 42
HYDROCHLOROTHIAZIDE 196 189 44 9
SPIRONOLACTONE 195 143 45 86
LACTASE 181 126 10 46 393
ALENDRONATE SODIUM 181 176 46 20
SENNA S 175 142 10 48 303
DETROL LA 175 163 48 217
IPRATROPIUM BROMIDE 168 166 50 157
FOLIC ACID 164 163 51 330
VITAMIN D 159 147 52 369
QUETIAPINE FUMARATE 154 145 53 72
LANTUS 154 154 53 70
ATENOLOL 153 147 55 14
DAILY VITE 146 146 56 318
PLAVIX 143 124 57 41
DILTIAZEM 24HR CD 143 133 57 148
SORBITOL 142 129 10 59 421
DIVALPROEX SODIUM 142 140 59 90
MUCINEX 140 128 10 61 361
MAGNESIUM OXIDE 135 88 10 62 384
LOSARTAN POTASSIUM 132 132 63 18
LEVETIRACETAM 127 91 64 94
GLIPIZIDE 125 125 65 71
METFORMIN HCL 125 107 65 6
MYTAB GAS 124 105 10 67 441
ESCITALOPRAM OXALATE 124 124 67 82
FINASTERIDE 124 115 67 80
LYRICA 117 93 70 107
ADVAIR DISKUS 116 116 71 32
ABILIFY 113 110 72 192
DIOVAN 111 111 73 26
OYSTER SHELL CALCIUM W-VIT D 109 109 74 338
OYST-CAL-D 106 106 10 75 467
TAMIFLU 106 102 75 136
PHENYTOIN SODIUM EXTENDED 105 97 77 207
ALPRAZOLAM 102 94 78 235
LIDODERM 98 94 79 74
ARTIFICIAL TEARS 97 93 80 389
ROPINIROLE HCL 97 90 80 143
SPIRIVA 94 88 82 36
SIMVASTATIN 93 81 83 1
ISOSORBIDE MONONITRATE ER 93 89 83 57
BYSTOLIC 92 84 85 104
CALCIUM 90 88 10 86 391
CALCITRIOL 87 84 87 321
CALCIUM ANTACID 86 78 10 88 483
JANUVIA 85 85 89 34
CIPROFLOXACIN HCL 85 81 89 85
FLUTICASONE PROPIONATE 84 72 91 38
ARICEPT 83 76 92 380
CLONIDINE HCL 81 81 93 84
GLIPIZIDE XL 79 79 94 87
PAROXETINE HCL 78 78 95 62
BUPROPION XL 78 68 95 233
TRICOR 78 78 95 115
Q-PAP 76 53 10 98 440
IPRATROPIUM-ALBUTEROL 75 70 99 110
METOLAZONE 75 46 99 262
AMIODARONE HCL 73 73 101 277
POLYETHYLENE GLYCOL 3350 70 61 102 55
TIZANIDINE HCL 70 18 102 282
AGGRENOX 70 18 102 284
PROPRANOLOL HCL 69 69 105 158
MAPAP 69 68 105 327
TORSEMIDE 68 39 107 169
LORAZEPAM 66 65 108 313
LATANOPROST 64 64 109 195
FENTANYL 64 64 S2 109 102
VENTOLIN HFA 62 58 111 61
LANTUS SOLOSTAR 61 40 112 68
OPTI-VITAMIN 58 58 10 113 528
INSTA-GLUCOSE 56 47 10 114 542
BUMETANIDE 55 55 115 225
AMOX TR-POTASSIUM CLAVULANATE 55 52 115 145
SINGULAIR 55 40 115 64
NOVOFINE AUTOCOVER 54 41 118 361
MILK OF MAGNESIA 54 53 10 118 546
QUINAPRIL HCL 53 0 120 79
COMTAN 53 45 120 550
SEROQUEL 52 52 122 161
KLOR-CON M10 51 51 123 185
TRAZODONE HCL 50 42 124 60
INSULIN SYRINGE 50 48 124 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.